European Transcervical Female Sterilization Market Sees Double-Digit
VANCOUVER, July 12, 2011 /PRNewswire/ - According to a new report by iData
Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical
market research, the European women's health market is valued at over
$917 million, and is estimated to grow to $1.1 billion by 2017 due to
recovery of the digital breast imaging, OB/GYN ultrasound imaging and
female sterilization segments. Implementation of national breast
screening programs by European health authorities is expected to
counteract the negative effects of the global economic crisis,
resulting in double-digit growth of the European digital mammography
market by 2017.
"Many European countries are implementing national breast screening
programs and converting to digital mammography, stimulating growth in
this market," says Dr. Kamran Zamanian, CEO of iData. "In addition, new
technologies such as tomosynthesis from GE, Siemens, Hologic will fuel
unit sales and pushing up prices."
The report states that in 2010, the OB/GYN ultrasound accounted for more
than one-quarter of the total European women's health market and will
continue to grow due to technological advances from GE, Siemens and
Philips such as 3D/4D real-time imaging. These new systems allow for
easier detection of fetal abnormalities and high-risk pregnancies.
In addition, the European transcervical female sterilization market is
expected to grow at double-digit rates through 2017. France represented
the majority of this market followed by Spain due to their positive
reimbursement policies. Transcervical devices were not reimbursed or
only partially reimbursed in many other European countries, which is
the greatest barrier to movement in this market. Tremendous growth is
expected as more countries approve this device for reimbursement such
as Germany, which currently offers no reimbursement.
iData's 3-report series on the U.S., European and Asia-Pacific "Markets
for Women's Health Devices 2011" also includes bone-densitometry,
breast-biopsy, fetal/neonatal monitoring, assisted-reproduction,
global-endometrial ablation, endometrial resection, uterine fibroid
embolization, hysteroscopes, colposcopes, urinary-incontinence,
pelvic-floor electrical stimulation and repair, fluid-management,
infant warmers/incubators, gynecological chairs.
For more information, register free on iData's website at:
About iData Research
iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on
providing market intelligence for medical device and pharmaceutical
companies. iData covers research in: women's health, urology, endoscopy
SOURCE iData Research Inc.